Natriuretic peptides and hemodynamics in preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 4, 2007, Pages 328.e1-328.e7

  Tihtonen, Kati M ^a   Kööbi, Tiit ^a   Vuolteenaho, Olli ^c   Huhtala, Heini S ^b   Uotila, Jukka T ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

hemodynamics; natriuretic peptides; NT proANP; NT proBNP; preeclampsia

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INDEX; HEART RATE; HEART STROKE VOLUME; HEART WORK; HEMODYNAMIC MONITORING; HUMAN; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PEPTIDE ANALYSIS; PREECLAMPSIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STROKE INDEX; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; VASCULAR RESISTANCE;

EID: 33947628634     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.11.033     Document Type: Article

References (35)

1. Stoupakis G., and Klapholz M. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Heart Dis 5 (2003) 215-223
2. Cowie M., Struthers A., and Wood D. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1347-1351
3. Yamamoto K., Burnett J., and Jougasaki M. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28 (1996) 988-994
4. Fievet P., Fournier A., de Bold A., el Esper N., Gregoire I., Westeel P., et al. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possible explaining these hypovolemic states with paradoxical hyporeninism. Am J Hypertension 1 (1988) 16-21
5. Otsuki Y., Okamoto E., Iwata I., Nishino E., Mitsuda N., Mori M., et al. Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia. J Endocrinol 114 (1987) 325-328
6. Mikkelsen A., Schutten G., Asping U., and Schutten H. Plasma concentration of atrial natriuretic peptide in normal pregnant women and in pregnant women with preeclampsia. Gynecol Obstet Invest 31 (1991) 192-195
7. Pouta A., Karinen J., Vuolteenaho O., and Laatikainen T. Pre-eclampsia: the effect of intravenous fluid preload on atrial natriuretic peptide secretion during cesarean section under spinal anesthesia. Acta Anaesthesiol Scand 40 (1996) 1203-1209
8. Pouta A., Vuolteenaho O., and Laatikainen T. An increase of the plasma N-terminal peptide of proatrial natriuretic peptide in preeclampsia. Obstet Gynecol 89 (1997) 747-753
9. Itoh H., Sagawa N., Mori T., Mukoyama M., Nakao K., and Imura H. Plasma brain natriuretic peptide level in pregnant women with pregnancy-induced hypertension. Obstet Gynecol 82 (1993) 71-77
10. Nisell H., Carlström K., Cizinsky S., Grunewald C., Nylund L., and Randmaa I. Atrial natriuretic peptide concentrations and hemodynamic effects of acute plasma volume expansion in normal pregnancy and preeclampsia. Obstet Gynecol 79 (1992) 902-907
11. Frenkel Y., Blonder J., Mashiach S., and Weiss M. Atrial natriuretic peptide plasma level remains unchanged in various hypertensive disorders of pregnancy. Eur J Obstet Cynecol Reprod Biol 59 (1995) 197-200
12. Irons D., Baylis P., Butler T., and Davison J. Atrial natriuretic peptide in preeclampsia: metabolic clearance, sodium excretion and renal hemodynamics. Am J Physiol 273 (1997) 83-87
13. Borghi C., Esposti D., Immordino V., Cassani A., Boschi S., Bovicelli L., et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol 183 (2000) 140-147
14. Mabie W., Ratts T., and Sibai B. The central hemodynamics of severe preeclampsia. Am J Obstet Gynecol 161 (1989) 1443-1448
15. Yang J.-M., Yang Y.-C., and Wang K.-G. Central and peripheral hemodynamics in severe preeclampsia. Acta Obstet Gynecol Scand 75 (1996) 120-126
16. Groenendijk R., Trimbos J., and Wallenburg H. Hemodynamic measurements in preeclampsia: preliminary observations. Am J Obstet Gynecol 150 (1984) 232-236
17. Lang R., Pridjian G., Feldman T., Neumann A., Lindheimer M., and Borow K. Left ventricular mechanics in preeclampsia. Am Heart J 121 (1991) 1768-1775
18. Kööbi T., Kaukinen S., Turjanmaa V., and Uusitalo A. Whole-body impedance cardiography in the measurement of cardiac output. Crit Care Med 25 (1997) 779-785
19. Kööbi T. Non-invasive cardiac output determination: a state of the art. Cur Opin Anaesthesiol 12 (1999) 9-13
20. Kööbi T., Kaukinen S., Turjanmaa V., and Uusitalo A. Whole-body impedance cardiography in the measurement of cardiac output. Crit Care Med 5 (1997) 779-785
21. Visser W., and Wallenburg H. Central hemodynamics observations in untreated preeclamptic patients. Hypertension 17 (1991) 1072-1077
22. Ala-Kopsala M., Magga J., Peuhkurinen K., Leipälä J., Ruskoaho H., Leppäluoto J., et al. Molecular heterogenetity has a major impact on the measurements of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588
23. Lee R., Bloch K., Prefer J., Sneer E., and Seidman C. Atrial natriuretic factor gene expression in ventricles of rats with spontaneuos biventricular hypertrophy. J Clin Invest 81 (1988) 431-434
24. Hunt P., Richards A., Nicholls M., Yandle T., Doughty R., and Espiner E. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 47 (1997) 287-296
25. Castro L., Hobel C., and Gornbein J. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol 171 (1994) 1642-1651
26. Bond A., August P., Druzin M., Atlas S., Sealey J., and Laragh J. Atrial natriuretic factor in normal and hypertensive pregnancy. Am J Obstet Gynecol 160 (1989) 1112-1116
27. Paarlberg K., de Jong C., van Geijn H., van Kamp G., Heinen A., and Dekker G. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study. Am J Obstet Gynecol 176 (1998) 1559-1564
28. G-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology 136 (1995) 1241-1249
29. Seligman S., Buyon J., and Clancy R. The role of nitric oxide in the pathogenensis of preeclampsia. Am J Obstet Gynecol 171 (1994) 944-948
30. Pouta A., Vuolteenaho O., and Laatikainen T. An increase of the plasma N-terminal peptide of proatrial natriuretic peptide in preeclampsia. Obstet Gynecol 89 (1997) 747-753
31. Fleming S., O′Byrne L., Grimes H., Daly K., and Morrison J. Amino-terminal pro-brain natriuretic peptide in normal and hypertensive pregnancies. Hypert Preg 20 (2001) 169-175
32. Valensise H., Novelli G., Vasapollo B., Borzi M., Radii D., Galante A., et al. Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study. Ultrasound Obstet Gynecol 15 (2000) 487-497
33. Mesa A., Jessurun C., Hernandez A., Adam K., Brown D., Vaughn W., et al. Left ventricular diastolic function in normal human pregnancy. Circulation 99 (1999) 51-57
34. Mabie W., DiSessa T., Crocker L., Sibai B., and Arheart K. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 170 (1994) 849-856
35. Milsom I., Hedner J., and Hedner T. Plasma atrial natriuretic peptide and maternal hemodynamic changes during normal pregnancy. Acta Obstet Gynecol Scand 67 (1988) 712-722